David Dayen writes: Juul is spending millions in lobbying and persuasion to get the FDA’s green light to continue operations. But a Tuesday New York Times article on the subject contained a fascinating nugget midway through, which could be described as a buried lede (journalese for putting the most explosive part of a story in the middle … Continue reading Academic corruption by Juul →